FDA Inspection
BioLife Plasma Services, L.P.BioLife Plasma Services, L.P. – FDA Inspection, Jun 8, 2026
Record Details
This FDA Inspection record concerns BioLife Plasma Services, L.P., with an inspection on June 8, 2026, issued by the Denver District Office, covering biologics.
- Office
- Denver District Office
- Person
View Company Profile
ID · bfbafac9-010e-4fff-8f4d-f49fb3f121be
Inspection Facts
- Inspection number
- 1321128
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.100(b)(9)Written methods for investigating adverse reactions
- 21 CFR 606.170(a)Adverse Reaction - Investigations
- 21 CFR 606.60(a)Maintain and clean equipment
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLife Plasma Services, L.P.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2018 | Not classified | Denver District Office |
Other documents for BioLife Plasma Services, L.P.
- FDA Inspection 1074144 - 2018-11-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.